Polynoma Receives FDA Fast Track Designation for its Melanoma Cancer Vaccine Seviprotimut-L

SAN DIEGO, June 23, 2020 -- (Healthcare Sales & Marketing Network) -- Polynoma LLC, a U.S. immuno-oncology focused biopharmaceutical company and wholly-owned subsidiary of Hong Kong-listed CK Life Sciences Int'l., (Holdings) Inc., announces that the U.S. ... Biopharmaceuticals, Oncology, FDA Polynoma, Seviprotimut-L, Melanoma, Cancer Vaccine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news